Mirae Asset Global Investments Co., Ltd. Poseida Therapeutics, Inc. Transaction History

Mirae Asset Global Investments Co., Ltd.

  • $24 Billion
  • Q4 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 24, 2024
SELL
$1.83 - $3.51 $267,029 - $512,172
-145,918 Reduced 56.14%
114,011 $383,000
Q3 2023

Oct 26, 2023
BUY
$1.62 - $2.79 $38,815 - $66,848
23,960 Added 10.15%
259,929 $618,000
Q2 2023

Aug 10, 2023
BUY
$1.66 - $3.4 $391,708 - $802,294
235,969 New
235,969 $415,000

Others Institutions Holding PSTX

# of Institutions
119
Shares Held
40.7M
Call Options Held
135K
Put Options Held
439K
View Full List

About Poseida Therapeutics, Inc.

PSTX Quotes by TradingView
  • Ticker PSTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 85,775,600
  • Market Cap $815M
  • Description
  • Poseida Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for patients with high unmet medical needs. The company develops P-PSMA-101, an autologous chimeric antigen receptor T cell (CAR-T) product candidate that is in Phase I trial for the treatment of patients with metastatic castrate resistant ...
More about PSTX
Track This Portfolio

Track Mirae Asset Global Investments Co., Ltd. Portfolio

Follow Mirae Asset Global Investments Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirae Asset Global Investments Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mirae Asset Global Investments Co., Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email